Logo image
Feasibility/Acceptability of an Acceptance-Based Therapy Intervention for Diverse Adolescent Cisgender Girls With Overweight/Obesity
Journal article   Open access   Peer reviewed

Feasibility/Acceptability of an Acceptance-Based Therapy Intervention for Diverse Adolescent Cisgender Girls With Overweight/Obesity

Michelle Cardel, Alexandra Lee, Xiaofei Chi, Faith Newsome, Darci Miller, Angelina Bernier, Lindsay Thompson, Matthew Gurka, David Janicke and Meghan Butryn
Current developments in nutrition, v 5(Supplement_2), pp 1201-1201
07 Jun 2021
url
https://doi.org/10.1093/cdn/nzab055_011View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

Abstract Objectives This study assessed the feasibility and acceptability of an ABT healthy lifestyle intervention among diverse adolescent cisgender girls with overweight/obesity (OW/OB). Methods Adolescent cisgender girls ages 14 to 19 with a BMI ≥ 85th percentile-for-sex-and-age were recruited for participation in a single-arm feasibility study. The primary outcomes were recruitment and retention while the secondary outcome was change in BMI Z-score over the 6-month intervention. Exploratory outcomes included obesity-related factors, health-related behaviors, and psychological factors. Results Recruitment goals were achieved; thirteen adolescents (>60% racial/ethnic minorities) participated in the intervention, and eleven completed the intervention (85% retention). In completers (n = 11), a mean decrease in BMI Z-score of −0.15 (SD = 0.34, Cohen's d = −0.44) was observed. Improvements were also noted for change in percentage of 95th percentile (d = −0.35), % body fat (d = −0.35), quality of life (d = 0.71), psychological flexibility (d = −0.86), and depression (d = −0.86). Conclusions These preliminary findings suggest an ABT healthy lifestyle intervention tailored for adolescent cisgender girls with OW/OB may be an acceptable treatment that could lead to improvements in BMI Z-score, obesity-related measures, and psychological outcomes. Funding Sources This work is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH; UL1TR001427) and WellCare Health Plans, Inc. Dr. Cardel is also supported by the National Institutes of Health National Heart, Lung, and Blood Institute (K01HL141535 and R25HL126146).

Metrics

16 Record Views

Details

Logo image